Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

Authors
Publication date
1 January 2009
Publisher
Springer-Verlag
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Springer - Publisher Connector

      redirect
      Last time updated on 04/06/2019

      Springer - Publisher Connector

      redirect
      Last time updated on 28/04/2017

      Crossref

      redirect
      Last time updated on 01/04/2019